Duality Advisers, LP Alector, Inc. Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$19.35 - $25.54 $781,604 - $1.03 Million
-40,393 Closed
0 $0
Q3 2021

Nov 08, 2021
BUY
$21.65 - $39.49 $874,508 - $1.6 Million
40,393 New
40,393 $922,000
Q1 2021

May 13, 2021
SELL
$14.84 - $22.23 $1.07 Million - $1.61 Million
-72,243 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$9.4 - $16.7 $679,084 - $1.21 Million
72,243 New
72,243 $1.09 Million

Others Institutions Holding ALEC

# of Institutions
168
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email